DK0641861T3 - Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider - Google Patents

Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider

Info

Publication number
DK0641861T3
DK0641861T3 DK94109676T DK94109676T DK0641861T3 DK 0641861 T3 DK0641861 T3 DK 0641861T3 DK 94109676 T DK94109676 T DK 94109676T DK 94109676 T DK94109676 T DK 94109676T DK 0641861 T3 DK0641861 T3 DK 0641861T3
Authority
DK
Denmark
Prior art keywords
proteins
peptides
hydrophobic polypeptides
producing hydrophobic
purification
Prior art date
Application number
DK94109676T
Other languages
English (en)
Inventor
Nicholas Draeger
Trottman Gerda Huber
Peter Jakob
Dietrich Stueber
Heinz Doebeli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0641861T3 publication Critical patent/DK0641861T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94109676T 1993-07-06 1994-06-23 Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider DK0641861T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93110755 1993-07-06

Publications (1)

Publication Number Publication Date
DK0641861T3 true DK0641861T3 (da) 2003-07-28

Family

ID=8213046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94109676T DK0641861T3 (da) 1993-07-06 1994-06-23 Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider

Country Status (14)

Country Link
US (1) US5750374A (da)
EP (2) EP1304381A3 (da)
JP (2) JP2947401B2 (da)
CN (3) CN1057535C (da)
AT (1) ATE236984T1 (da)
AU (1) AU666274B2 (da)
CA (1) CA2125467C (da)
DE (1) DE69432449T2 (da)
DK (1) DK0641861T3 (da)
ES (1) ES2194017T3 (da)
NZ (1) NZ260907A (da)
PT (1) PT641861E (da)
RU (1) RU94023251A (da)
ZA (1) ZA944686B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817626A (en) * 1995-03-14 1998-10-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation
US5854215A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals Incorporated Modulators of β-amyloid peptide aggregation
US6303567B1 (en) 1995-03-14 2001-10-16 Praecis Pharmaceuticals, Inc . Modulators of β-amyloid peptide aggregation comprising D-amino acids
ES2175083T3 (es) * 1995-03-14 2002-11-16 Praecis Pharm Inc Moduladores de la agregacion de amiloides.
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process
US6277826B1 (en) 1996-08-27 2001-08-21 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
US5985242A (en) * 1995-10-27 1999-11-16 Praecis Pharmaceuticals, Inc. Modulators of β-amyloid peptide aggregation comprising D-amino acids
CA2362834C (en) 1999-03-04 2005-12-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation comprising d-amino acids
US7569660B1 (en) 1999-06-09 2009-08-04 The University Of Chicago Recombinant prion-like proteins and materials comprising same
CA2387646A1 (en) * 1999-10-21 2001-04-26 Kalobios, Inc. A general method for optimizing the expression of heterologous proteins
US7799561B2 (en) * 2002-06-12 2010-09-21 Sigma-Aldrich, Co. Affinity peptides and method for purification of recombinant proteins
FR2859221B1 (fr) * 2003-08-28 2005-10-14 Centre Nat Rech Scient Vecteur de co-expression de domaines membranaires de proteines d'enveloppe d'un virus et utilisations
US7741053B2 (en) * 2005-05-13 2010-06-22 Sigma-Aldrich Co. Processes for purification of recombinant proteins
KR100621354B1 (ko) * 2005-06-14 2006-09-08 광주과학기술원 유비퀴틴을 이용한 아밀로이드-베타 펩티드의 제조방법
WO2010063460A1 (en) * 2008-12-02 2010-06-10 Universität Zürich Recombinant production of hydrophobic peptides and fusion proteins for use in producing same
US20170226159A1 (en) * 2014-09-26 2017-08-10 Kaneka Corporation Method for producing hydrophobic peptide
ES2952405T3 (es) 2014-12-01 2023-10-31 Pfenex Inc Parejas de fusión para la producción de péptidos
CN105001307B (zh) 2015-07-31 2016-08-24 南京斯拜科生化实业有限公司 一种溶解难溶多肽的偶联肽链及其在液相色谱中分离纯化的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207044A1 (en) * 1985-06-20 1986-12-30 Monsanto Company Release of peptides from polypeptides
AU6104586A (en) * 1985-08-12 1987-02-19 Malcolm A. Martin Aids protein using trple gene
EP0261224B2 (en) * 1986-03-24 2003-03-26 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
CA1304886C (en) * 1986-07-10 1992-07-07 Heinz Dobeli Metal chelate resins
US5047513A (en) * 1986-07-10 1991-09-10 Hoffmann-La Roche Inc. Metal chelate resins
CA1329124C (en) * 1987-02-02 1994-05-03 Jerald C. Sadoff Conjugate malaria vaccine
CA1340522C (en) * 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US5416007A (en) * 1987-03-20 1995-05-16 Creative Biomolecules, Inc. Enhanced proteolytic cleavage of recombinant fusion proteins
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
IT1226728B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Coniugato peptidico immunologicamente attivo utile come vaccino antimalaria e metodo di immunizzazione impiegante lo stesso
US5045190A (en) * 1988-11-08 1991-09-03 Carbonell Ruben G Chromatography apparatus
JPH06507782A (ja) * 1990-06-15 1994-09-08 サイオス　ノバ　インコーポレイテッド アルツハイマー病のアミロイド形成開症状を示すヒト以外の組換え哺乳動物
JPH06500560A (ja) * 1990-08-24 1994-01-20 プレジデント アンド フェローズ オブ ハーバード カレッジ α―アンチキモトリプシン―β―タンパク質複合体形成妨害方法およびその方法に使用する合成ペプチド
DK0770679T4 (da) * 1990-11-03 2010-05-10 Siemens Healthcare Diagnostics HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
US5434050A (en) * 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease

Also Published As

Publication number Publication date
EP1304381A2 (en) 2003-04-23
EP0641861A3 (en) 1997-07-30
EP1304381A3 (en) 2003-05-02
ZA944686B (en) 1995-01-06
CN1916017A (zh) 2007-02-21
CA2125467C (en) 2001-02-06
US5750374A (en) 1998-05-12
RU94023251A (ru) 1996-05-10
AU6612294A (en) 1995-01-27
NZ260907A (en) 1996-06-25
DE69432449T2 (de) 2004-04-08
JPH07102000A (ja) 1995-04-18
AU666274B2 (en) 1996-02-01
CN1057535C (zh) 2000-10-18
JPH1143500A (ja) 1999-02-16
PT641861E (pt) 2003-07-31
EP0641861A2 (en) 1995-03-08
CN1227846A (zh) 1999-09-08
ES2194017T3 (es) 2003-11-16
CA2125467A1 (en) 1995-01-07
DE69432449D1 (de) 2003-05-15
CN100439391C (zh) 2008-12-03
ATE236984T1 (de) 2003-04-15
EP0641861B1 (en) 2003-04-09
JP2947401B2 (ja) 1999-09-13
CN1098416A (zh) 1995-02-08

Similar Documents

Publication Publication Date Title
DK0641861T3 (da) Fremgangsmåde til fremstilling af hydrofobe polypeptider, proteiner eller peptider
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
ES2166371T3 (es) Celulas de levadura tratadas para producir sustitutos de proteinas de sistemas de feromonas y usos de las mismas.
DK1144607T5 (da) Fremgangsmåde til præsentation af (poly)peptider/proteiner på bakteriofage partikler via disulfidbindinger
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
DK0489968T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DE69929019D1 (de) Mu-1, ein mitglied der zytokinrezeptor-familie
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
DE68925275D1 (de) Endotoxin-bindeprotein und dessen verwendung
ATE143669T1 (de) Hcg-peptide zur verwendung in antikörper- reinigungsverfahren
DE69010155D1 (de) Verfahren zur Trennung von Aminosäuren.
ATE189232T1 (de) Protein-s polypeptide und deren verwendungen
ATE139572T1 (de) Verfahren zur reinigung von rekombinanten proteinen und dafür nützliche produkte
ES2051816T3 (es) Procedimiento para la disociacion selectiva de proteinas de fusion.
DK0401657T3 (da) Fremgangsmåde til C-terminal modificering af proteiner
DE69000908D1 (de) Leichtes transportables brueckenteil zur ueberwindung von graeben.
ATE192163T1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
DE69000909D1 (de) Transportables brueckenteil zur ueberwindung von graeben.
NO901842L (no) Rekombinante fusjonsproteiner for endring av hormonutskillelse.
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung
DE59203874D1 (de) Schizosaccharomyces-spezifische Polypeptide.